M. Proctor

发表

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer

S. Clarke, D. McMillan, P. Horgan, 2012, British Journal of Cancer.

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.

D. Talwar, D. McMillan, D. O’Reilly, 2011, European journal of cancer.

An investigation into the relationship between the systemic inflammatory response and survival : a Glasgow Inflammation Outcome study

M. Proctor, 2014 .

Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study

D. Talwar, D. McMillan, P. Horgan, 2015, PloS one.

Optimization of the systemic inflammation‐based Glasgow Prognostic Score

D. Talwar, D. McMillan, P. Horgan, 2013, Cancer.

The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients

D. McMillan, H. Leung, K. Shafique, 2013, BMC Cancer.

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study

D. Talwar, D. McMillan, D. O’Reilly, 2011, British Journal of Cancer.

The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers

D. McMillan, P. Horgan, D. G. Watt, 2015, PloS one.

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study

D. Talwar, D. McMillan, D. O’Reilly, 2010, British Journal of Cancer.

Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study

D. McMillan, H. Leung, K. Shafique, 2011, Prostate Cancer and Prostatic Diseases.

Complications of peptic ulcers

C. Deans, M. Proctor, 2014 .

Abstract 3639: Systemic inflammation and survival of patients with prostate cancer: Evidence from the Glasgow Inflammation Outcome Study.

D. McMillan, K. Shafique, K. Qureshi, 2012 .